Ligand Pharmaceuticals, Inc. (LGND)
280.18
-6.11
(-2.13%)
USD |
NASDAQ |
Aug 24, 16:00
280.04
-0.14
(-0.05%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Assets (Quarterly) : 2.186B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.186B |
| March 31, 2026 | 1.532B |
| December 31, 2025 | 1.561B |
| September 30, 2025 | 1.477B |
| June 30, 2025 | 948.60M |
| March 31, 2025 | 905.44M |
| December 31, 2024 | 941.77M |
| September 30, 2024 | 954.87M |
| June 30, 2024 | 866.40M |
| March 31, 2024 | 913.87M |
| December 31, 2023 | 787.22M |
| September 30, 2023 | 769.23M |
| June 30, 2023 | 758.10M |
| March 31, 2023 | 811.08M |
| December 31, 2022 | 762.67M |
| September 30, 2022 | 1.051B |
| June 30, 2022 | 1.076B |
| March 31, 2022 | 1.105B |
| December 31, 2021 | 1.298B |
| September 30, 2021 | 1.274B |
| June 30, 2021 | 1.256B |
| March 31, 2021 | 1.295B |
| December 31, 2020 | 1.362B |
| September 30, 2020 | 1.247B |
| June 30, 2020 | 1.243B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.186B |
| December 31, 2019 | 1.495B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 1.802B |
| March 31, 2019 | 1.914B |
| December 31, 2018 | 1.313B |
| September 30, 2018 | 2.106B |
| June 30, 2018 | 1.858B |
| March 31, 2018 | 754.67M |
| December 31, 2017 | 722.65M |
| September 30, 2017 | 662.34M |
| June 30, 2017 | 640.02M |
| March 31, 2017 | 629.72M |
| December 31, 2016 | 601.58M |
| September 30, 2016 | 600.86M |
| June 30, 2016 | 589.32M |
| March 31, 2016 | 585.96M |
| December 31, 2015 | 503.06M |
| September 30, 2015 | 521.70M |
| June 30, 2015 | 304.76M |
| March 31, 2015 | 263.22M |
| December 31, 2014 | 258.03M |
| September 30, 2014 | 272.28M |
| June 30, 2014 | 99.85M |
| March 31, 2014 | 105.47M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Zevra Therapeutics, Inc. | 302.71M |
| Liquidia Corp. | 521.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.218B |
| Shareholders Equity (Quarterly) | 967.52M |
| Debt to Equity Ratio | 1.169 |
| Current Ratio | 31.18 |
| Net Debt Paydown Yield | -3.58% |